A new Enzyme Linked Immuno Sorbent Assay (ELISA) kit for the determination of serum ferritin has been compared with another ferritin kit based on the Immuno Radio-Metric Assay (IRMA) approach, both assays containing similar antibodies.
Introduction
Ferritin is the major storage protein of iron in the body. It is located mainly in the reticuloendothelial System and is found predominantly in the liver, spieen and bone marrow. The mean serum ferritin concentration correlates quite well with the total body iron störe in clinical conditions ranging from iron deficiency to iron overload. Increased serum ferritin levels can also be found in patients with some types of malignancy, liver disease and inflammation (1) (2) (3) (4) . The first immunoassay sensitive enough to detect ferritin in normal serum was developed by Addison et al. in 1972 (5) . In their assay, they employed an immunosorbent and 125 I-labeled anti-ferritin antibody and termed the technique an immunoradiometric assay (IRMA) to distinguish it from typical radioimmunoassays. Within 2 years, Miles et al. introduced an improved and simpler assay, which they designated äs a "two-side IRMA" (6) and numerous commercial kits have been developed based on this principle. With the preparation of highly purified ferritin it then became possible to develop a conventional radioimmunoassay (RIA) utilizing 125 I-labeled ferritin (7) . Since RIA and IRMA methodologies suffer from similar disadvantages (e.g., short reagent shelf lives, special requirements and restrictions for handling radioisotopes, radioactive waste disposal problems and the need for sophisticated gamma counting equipment) the development of suitable enzyme immunoassays was welcomed äs a great advance in clinical chemistry (8) (9) (10) (11) (12) (13) (14) .
Although the first enzyme immunoassays developed did not achieve the precision and the sensitivity shared by RIA and IRMA techniques (8, 9, 12) , later improvements in assay design enable them to compete with the radiometric assays (10, 11, 13, 14) . Ferritin enzyme immunoassays have now becqme commercially available (15) .
An ELISA method has recently been developed by the manufacturer of an IRMA kit; similar antibodies are used in both kits. We have evaluated the quality of this new ELISA.
Materials and Methods

Ferritin assay Systems
We used IRMA kits from Behringwerke AG, Marburg, Germany (RIA-gnost® Ferritin) and from Ramco Laboratories, Houston Texas 77098, USA (Fer-iron®) and an ELISA kit from Ramco Laboratories (Spectro Ferritin®) for this sitfdy.
RIA-gnosft Ferritin
An evaluation has been reported by Thornton & Waters (16) . We performed the assay according to the package insert instructions. The sample requirement for a single assay is 100 , but to corhpensate for limited linearity, we used 50 . Data reduction is performed by means of a weighted linear regression using a logit-log calculation (17) . We utilized a Computer program capable of curve-fitting and rejecting those results falling outside the 95% confidence ränge of the regression line. The kit's expiration date is generally about 7 weeks after delivery.
Fer-iron®
This commercial assay is similar in its design to that described by Miles et al. (6) .
Depehding on he actual procedure used, the required sample vol ume for a single determination is either 10 or 20 . The total minimum incubätion time cpnsists of either 4 hours or 90 minutes and for our evaluation we employed the 4 hour procedure. For the calculation of the results the manufacturer recofnmends the logitlog method, and we performed this calculation with the aid of the computerized weighted logit-log program. The kit has a shelf life of about 12 weeks when stored at 2-8 °C.
Spectro Ferritin®
This kit is identical to the Fer-iron® kit with the exception that the alkaline phosphatase label and the Substrate p-nitrophenyl phosphate have replaced the radioisotope. We carried out the assay essentially äs recommended by the manufacturer. However, the manufacturer points out that the ihvestigator has the Option of varying the incubätion period äs with the Fer-iron® assay. We en> ployed for our study a sample volume ofclO and a total incubä-tion time of 4.5 hours. We calculated the results using the same Computer searching logit-log program äs we employed for the IRMA approach. The kit expires in about 10 months.
Sample handling
All samples are kept ffozefi at -20 °C until analysis.
Results
Standard cürve
Figure l represents the mean of 36 Standard curves of Spectro Ferritin® obtained in our evaluation. We observed differences between the four lot numbers tested (001, 003, 004 and 005) with lot 003 exhibitihg high absorbance values (up to A = 2.000 for the 2000 g/I Standard). This finding was coftfirmed by the manufacturer and an improvement was then made by using a shorter incubätion period for the determination of enzyme activity. Lot 001 ffequently showed poor duplication of the 2000 g/l Standard with absorbance differences up to 0.400 A. We observed an improvement with the qther lot numbers. Hormones in Normal and Abnormal Human Tissues is a threevolume monograph dealing with the circulating levels, the pathological and therapeutic conditions and the factors controlling the secretion of non-polypeptide, protein and steroid hormones. An attempt has been made to place emphasis on the concentration of the various hormones in tissues; where they are produced and where they might localize and prödüce an effect, and how these levels are mödified under various circumstances.
Hormone Antagonists
1982.17 cm 24 cm. IX, 734 pages. NymeroUs-illustratigns. Hardcover. DM 180,-; approx. US $85.75 ISBN 3110086131 This book groups together under one single cover antagonists for those hormones where antagonism has been documented specifically and with a certain degree of certitude. The major emphasis has been delineation of anti-hormone activity at the level of the hormone receptor but other äspects, such äs antibody mediated antagonism and Inhibition of synthesis, have been included to indicate other possible levels of Inhibition of hormone activity. Clinical aspects, too, have been covered where they were documented with certitude. It is feit that the book represents a major new reference source for years to come. Scientists, medical academicians^ and advanced graduate students may use the book äs a depärtihg point for further pursuit of their öwn field. Involved researoh workers will find the volume of much interest since it provides data not published elsewhere. The book may also be üsed äs a text volume to indicate the diversity and the wealth of Information on the subject of hormone antagonism both in the basic research and in clinical medicine. Photo-offset method of publication assures expediency before specialized articles obsolete novelty.
Prices are subject to change without notice. Upon storage of the kits the absorbance values decreased gradually (by 5-20% up to the expiry date), but without any detectable influence on the results. Further stability problems were not encountered.
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Sensitivity
We evaluated sensitivity in terms of "lowest detection limit", s defined by Schuurs & Van Weemen (18) . In one assay we evaluated 20 zeros in duplicate and determined the sensitivity by calculating the 95% confidence limits at the zero point of the Standard curve.
Based on this approach, we found the sensitivity for the Spectro Ferritin® to be l .4 μ §/1, corresponding to 14 pg per bead, with the assay requiring 10 μΐ serum.
Fer-iron® has a sensitivity of 0.9 μg/l, corresponding to 9 pg per bead.
Precision
We performed precision studies using serum pools containing low, normal and high ferritin levels (tab. l)/ With Fer-iron® we obtained a considerable higher mean value for pool serum III than with Spectro Ferritin®. This is a result of the fact that the 600 μg/l Standard does not exactly fit the linear regression line of the logit-log calculation method for Feriron®. This Standard point lies in most cases above the Standard curve, causing an overestimation in that area. We have reconstructed the Standard curves manually so that Standard point 600 μg/l fitted the curves and recalculated the values for serum pool III. This results in a mean ferritin concentration of 624 μg/ϊ instead of 720 μg/l (tab. 2).
Recovery
Recovery studies have been performed by adding ferritin Standards to sera with different ferritin concentrations. The recovery study results are expressed s the relative amount of added ferritin found after assay determination. The average recovery was 103 ± 13% (n = 17) for a final concentration r nge of 28-1950 μg/l.
Linearity
The serum pools containing serially diluted (11-fold) normal and high ferritin levels were also analysed in separate runs. The assay results are listed in table 3. It is unlikely that the hook effect caused invalid ferritin results below 1000 μ §/1, because this would be detected during the sample comparison with the RI A-gnost® assay (the latter requiring sample predilution at a low level).
Interference
Serum samples containing high and low ferritin concentrations and above normal concentrations of possible interfering substances were analysed with the Spectro Ferritin® method.
The following substances do not produce any significant interference: 19 mmol/1 triglycerides, 50 g/l human albumin, 100 g/l human γ-globulins, 500 μπιοΐ/ΐ bilirubin and 0.05-0.2 mmol/1 haemoglobin.
When we compared the ferritin concentration of EDTA-plasma (7.2 mg of EDTA per 5 ml of blood) with that of serum we observed a decrease of 6% in the plasma (n = 10; p < 0.05). EDTA-plasma also gives 6% lower values compared with serum when assayed with the Fer-iron® kit. However we obtained 1% higher values with EDTA-plasma s compared with serum by using the RIA-gnost® assay. Increasing the EDTA concentrations to 10 g/l blood has no further influence on these results.
Comparison of methods
We determined ferritin levels of 1-2000 μg/l in the sera of 127 healthy persons and patients, using the Spectro Ferritm® and the Fer-iron® kits. We did not predilute the sera . Fig re 3 illustrates these results. Due to the wide r nge of the concentrations found, the logarithm of the concentrations were compared.
The sign test and the Wilcoxon matched-pairs test revealed that at a level of α = 0.05 the Fer-iron® results are significantly higher than those of Spectro Ferritin® (p = 0.01 and p < 0.0001 respectively). speciraens 90 were male and 100 were female. We excluded from this study blood donors or persons who had abnormal levels of serum iron, transferrin or abnormal routine haematological parameters (RBC, Hb, Ht, MCV, MCH, MCHC). The levels found in women were lower than in men and were age dependent ( fig. 5) 
Discussion
The Spectro Ferritin® assay (ELISA) is just s practicable s the Fer-iron® assay (IRMA). While the Spectro Ferritin® assay has the advantage that no special precautions have to be taken against radioactive contamination, it does necessitate an extra incubation step of 1/2 hour for the determination of the enzyme activity, producing a total incubation time of 4.5 hours. Another disadvantage of the Spectro Ferritin® kit is the cost. The price per bead is about 12% higher than those of Fer-iron® and RIA-gnost®. It is evident that expensive gamma counting equipment is not required. In our hands the data reduction by logit-log transformation applied better to the Spectro Ferritin® assay than to the RIA-gnost® or Fer-iron® Systems, even though the logit-log method is advised for the latter assay. Another great advantage of the Spectro Ferritin® assay is the long shelf life (about 10 months) without detectable stability problems. The sensitivity of Spectro Ferritin® (detection limit: 1.4 μ{>/1 or 14 pg/bead) corresponds well with not only those of other ferritin ELISA's (12.5 pg/tube (10) and 10 pg/tube (11)) but also with that of Feriron® (detection limit: 0.9 μg/l or 9 pg/bead). Miles et al. (6) reported for their IRMA a sensitivity of 29 pg/tube). If we also consider the normal values of ferritin, the detection limit of Spectro Ferritin® seems to be low enough to quantitate ferritin in the serum of patients with iron deficiency.
Based on our precision studies, the Spectro Ferritin® kit works s well s the Fer-iron® method. The within-run precisipn for Fer-iron® is slightly better than one observes with Speetro Ferritin®, but the between-run precision does not show any great differences in either the normal or low levels (tab. 1). However, we note that the precision of Spectro Ferritin® is better than many other comrnercial radiometric assays, showing CV's up to 27% between-run (19) . A general problem of IRMA and ELISA procedures has been the "high dose hook effect", first described by Miles et al. (6) . Since the influence of this effect is assay dependent (20-23), one must evahiate this effect for every ELISA or IRMA System. A number of counter measures have been proposed but in practice the qtiality of a test kit is crucial. In our ev luation of the Spectro Ferritin® assay we found no high dose hook effect up to 40000 μg/l ( fig. 2) . If we use an upper linearity limit of 1000 μg/l, the hook effect is very unlikely to occur and in most cases we do not have to estimate our samples t two dilutions. However, we sometimes observed poor duplications of the results at high concentratioris, a phenomenon we also noted with the Fer-iron® kit. It is possible that minor differences in antibody coating of the beads are responsible for this effect.
Ferritin determinations on serial dilutions frequently reveal deviations from linearity above 1000 μg/l ( fig.  2, tab. 4 ). This phenomenon can also be observed using the Fer-iron® kit and agrees with the findings of Li et al. (22) . We question their explanatiori that the nonlinearity is d e to the high* dose hook effect, because the Standards and some sera show no deviation up to 2000 g/l and also because we noted good recoveries up to levels of 1950 §/1. We recommend diluting and reassaying those serum samples possessing ferritin concentrations above 1000 g/l. fig. 4) . Spleen Standards do not parallel liver Standards äs assayed with the RIA-gnost® kit. Slight differences when using liver and spieen Standards have also been reported in the literature (27, 28).
The normal values we found correspond very well with those observed with Fer-iron® (23) (tab. 5).
Our values do not demonstrate extreme concentrations äs compared with other ferritin assays (2). The age dependencies correspond very well with earlier findings* (29).
We conclude that the Substitution of the radioactive label by an enzyme tag does not reduce the reliability of the ferritin immunoassay.
